Biohaven

04/06/2026

Parkinson’s disease affects millions of people worldwide, yet many questions remain about how the disease begins and progresses.
Emerging research suggests that brain inflammation may play an important role. We are studying an investigational therapy designed to target the JAK/STAT pathway to better understand its potential role in Parkinson’s disease. This Parkinson’s Awareness Month, we recognize the importance of continued research to help advance the science forward. Learn more about our clinical trial: https://brnw.ch/21x1lZy

03/25/2026

“IT CAN MAKE YOU FEEL ALONE.”
David’s story is a reminder that is more than what people see, it affects daily life in ways many don’t realize. On Epilepsy Awareness Day, we thank him for sharing his story and helping shine a light on the realities of living with this disorder.
Learn more about our research: https://bit.ly/3PE2y9u

03/24/2026

Courtnay shares how her Graves’ disease diagnosis at a young age impacted her beyond the physical symptoms. It led to isolation, anxiety and a loss of confidence. Her story emphasizes the emotional toll of living with a chronic condition and reminds us why awareness and understanding matter. Hear more stories: https://brnw.ch/21x10k0

03/23/2026

We’re looking forward to being part of the upcoming Purple Day® Expo! On March 28, the epilepsy community will gather at Disney’s Coronado Springs Resort to share stories, resources and support for everyone impacted by epilepsy and Biohaven is proud to be there alongside them.
Join us: https://brnw.ch/21x0YqN

03/17/2026

March is , and we’re shining a light on IgA nephropathy (IgAN), a progressive kidney disease caused by the body’s immune system attacking itself. IgAN can lead to kidney damage and impact daily life, highlighting the urgent
need for new, targeted treatments. Every patient’s journey is unique, but understanding the disease is the first step toward hope.

03/12/2026

reminds us of the critical role kidneys play in overall health and the urgent need for new treatments for diseases like IgA nephropathy (IgAN).This progressive kidney disease can lead to renal failure within 10 to 15 years, affecting daily life, energy, and overall health. We are committed to advancing science that targets the root cause of IgAN and improving outcomes for patients living with this disease.

Learn more at: https://brnw.ch/21x0G7B

03/09/2026

This Brain Awareness Week, we’re highlighting Parkinson’s disease as a growing public ealth challenge affecting millions worldwide. We are committed to advancing research that addresses the root drivers of this devastating disease. Neuroinflammation plays a key role in disease progression, and our investigational therapy is designed to target this pathway. Through bold science and patientfocused innovation, we are working to change the trajectory of this disease. Learn more about our work in Parkinson’s: https://brnw.ch/21x0AGs

03/08/2026

Today, on , we’re proud to celebrate the extraordinary women of Biohaven.

Their bold ideas, fearless curiosity, and unwavering dedication fuel our mission and strengthen our culture every day. From advancing science to challenging the status quo, the women on our team play a vital role in helping us deliver meaningful therapies for patients.

We are grateful for their leadership, innovation, and impact — today and every day. 💜

03/04/2026

On , we recognize obesity as a complex, chronic disease affecting millions of people worldwide. We are committed to advancing new approaches to healthier weight management, including our investigational therapy, which is designed to reduce fat while preserving muscle.

02/28/2026

Our New Haven office lit up for ! In honor of , we joined National Organization for Rare Disorders, Inc. (NORD)’s global initiative to raise awareness for those living with rare diseases. Every light symbolizes hope, support and our commitment to making a difference.

02/20/2026

On February 23, the .S. Food and Drug Administration will host its virtual Rare Disease Day, “Moving Forward. Looking Ahead. An Event for Patients.” Patients, families, care partners and advocates are encouraged to attend and learn more about the FDA’s initiatives to advance medical product development for rare disease.
Learn more and register here: https://bit.ly/4kHLo6l

The public meeting will be held on February 23, 2025, from 9 a.m. to 4 p.m ET.

02/18/2026

Emma’s journey with Graves’ disease reflects the challenges of acceptance and learning to live with a chronic condition. Her story reminds us that a diagnosis does not define a person.
To learn more about Graves’ disease, visit: UnmaskGravesDisease.com